Psychedelics Road Ahead: Are We Ready?
Psychedelics are classed as a schedule I substance under the Controlled Substances Act of 1970 because of the potential for mind-changing effects. In vulnerable people, unsupervised use has the potential to lead to suicide. However, the management of end-of-life anxiety, severe resistant depression,...
Saved in:
| Main Author: | Mahesh R Gowda |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Jaypee Brothers Medical Publisher
2022-03-01
|
| Series: | Indian Journal of Private Psychiatry |
| Subjects: | |
| Online Access: | https://www.ijiapp.com/doi/IJPP/pdf/10.5005/jp-journals-10067-0113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
by: J Van Der Walt, et al.
Published: (2023-11-01) -
Psychedelic-assisted therapy - supposedly paradigm-shifting research with poor attempts at hypotheses falsifying and questionable ethics
by: Bor Luen Tang
Published: (2024-12-01) -
Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy
by: Joseph A. Zamaria, et al.
Published: (2025-02-01) -
What fMRI studies say about the nature of the psychedelic effect: a scoping review
by: Michal Beneš, et al.
Published: (2025-07-01) -
The Therapeutic Potential of Psychedelics in Treating Substance Use Disorders: A Review of Clinical Trials
by: Lavinia Hogea, et al.
Published: (2025-02-01)